What You Ought to Know:
– Israeli startup Salignostics, the developer and supplier of fast saliva-based checks for early being pregnant detection, in addition to COVID-19, cardiac threat, malaria, and different ailments, has closed an $8 million Sequence A funding spherical from non-public traders headed by angel investor Avigdor Orlinsky.
– The corporate has raised $16M to this point to help improvement, commercialization, and advertising efforts for the checks in Israel and abroad. It’ll additionally help the launch of a brand new plant presently below development within the Lavon Industrial Zone in Northern Israel.
Rework Saliva Into A Dependable Physique-Fluid for Lateral Stream Immunoassays
Salignostics was based in 2016 by a workforce of researchers on the Hebrew College of Jerusalem, (HU) who’ve a few years of expertise in cracking the secrets and techniques of saliva: Professor Aaron Palmon, a world-class researcher in saliva, and presently head of the Authority of Analysis College students in Experimental Sciences at HU; Dr. Omer Deutsch, who serves as CEO; Dr. Man Krief, Deputy CEO and Director of Enterprise Growth; Dr. Raluca Cohen, Chief Scientific Officer; and Dr. Yoav Neumann, Senior Researcher.
Following years of saliva scientific analysis, the 5 founders started commercializing their mental property by way of Yissum, the HU expertise switch firm, and developed user-friendly merchandise to precisely detect a spread of physiological situations together with being pregnant and COVID-19. The corporate additionally developed merchandise to detect malaria, cardiac threat, Helicobacter pylori and different ailments.
Throughout improvement of the checks, the corporate raised pre-seed and seed capital from non-public traders and obtained 4 grants from the Israel Innovation Authority.
The Salignostics’ workforce used their mental property to develop and provide SaliCov – a compact and correct self-test package for diagnosing COVID-19. SaliCov pilot checks demonstrated its effectivity in outbreak prevention by breaking the an infection chain within the earliest phases of the illness at academic and group facilities throughout Israel. The product is presently in use in Spain, and the corporate lately signed agreements for large-scale purchases with events in different nations.
The package has obtained Medical Units and Equipment (AMAR) approval from Israel’s Ministry of Well being for institutional Level of Care use, European CE-IVD approval to market the package throughout the European Union, and a prestigious RADx (Speedy Acceleration of Diagnostics Initiative for COVID-19) grant financed by the US Nationwide Institutes of Well being (NIH).
One other flagship product is SaliStick – the world’s first fast saliva-based being pregnant take a look at package. The package relies on revolutionary expertise which detects the being pregnant hormone β-hCG in saliva. Salistick has obtained European CE certification and Medical Units and Equipment approval from Israel’s Ministry of Well being.
“The capital raised will allow us to leverage the total enterprise potential of our proprietary platform, and profit from the robust pending demand. The platform units a brand new and breakthrough customary for fast checks basically and saliva-based checks specifically. The longer term diagnostics world will develop into more and more accessible to non-public and residential use, which may be accomplished anyplace by anybody. Salignostics’ expertise realizes this imaginative and prescient,” stated Dr. Omer Deutsch, co-founder, and CEO of Salignostics.